pharma news, views and analysis - pharmaphorum.com

Trending

in News
IL-6 drugs do work in COVID-19, says UK, as it plans NHS use
January 8, 2021 Share
X
IL-6 drugs do work in COVID-19, says UK, as it plans NHS use
https://pharmaphorum.com/news/il-6-drugs-covid-19-new-trial/
in News
Vulnerable should all get COVID-19 shot before summer, says NHS chief
December 29, 2020 Share
X
Vulnerable should all get COVID-19 shot before summer, says NHS chief
https://pharmaphorum.com/news/vulnerable-should-all-get-covid-19-shot-before-summer-says-nhs-chief/

Latest News

Amgen hands off leprosy, TB candidate to Australian non-profit

Amgen hands off leprosy, TB candidate to Australian non-profit

Amgen has decided that a drug for leprosy and tuberculosis it inherited as part of its acquisition of

X

Amgen hands off leprosy, TB candidate to Australian non-profit

https://pharmaphorum.com/news/amgen-hands-off-leprosy-tb-candidate-to-australian-non-profit/

NHS leaders urge UK government to extend Brexit transition period

NHS leaders urge UK government to extend Brexit transition period

NHS leaders have written to the UK prime minister urging him to extend the Brexit transition period by

X

NHS leaders urge UK government to extend Brexit transition period

https://pharmaphorum.com/news/nhs-uk-extend-brexit-transition/

Pandemic has little impact on pharma’s reputation, says report

Pandemic has little impact on pharma’s reputation, says report

The pandemic has had very little positive impact on the public’s perceptions of pharma although the industry has

X

Pandemic has little impact on pharma’s reputation, says report

https://pharmaphorum.com/news/pandemic-has-little-impact-on-pharmas-reputation-says-report/

Views & analysis

‘No going back’ for clinical trials after COVID

‘No going back’ for clinical trials after COVID

Trial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as

X

‘No going back’ for clinical trials after COVID

https://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/no-going-back-for-clinical-trials-after-covid/

How patient insights are changing trial solutions

How patient insights are changing trial solutions

Patients have been asking for patient-centric trial solutions for years – the industry just hasn’t been listening. That’s

X

How patient insights are changing trial solutions

https://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/how-patient-insights-are-changing-trial-solutions/

True patient-focused research through decentralised and hybrid trials

True patient-focused research through decentralised and hybrid trials

How can pharma improve the patient-centricity of its trials during COVID-19 and beyond? Experts from across the sector

X

True patient-focused research through decentralised and hybrid trials

https://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/true-patient-focused-research-through-decentralised-and-hybrid-trials/

Debates & Insights

Understanding blockchain – a practical guide for life sciences companies

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

X

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

How pharma can boost engagement by embracing support networks

How pharma can boost engagement by embracing support networks

Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking

X

How pharma can boost engagement by embracing support networks

https://pharmaphorum.com/patients/insights-patients/how-pharma-can-boost-engagement-by-embracing-support-networks/

Can simulated datasets unlock the potential of patient data?

Can simulated datasets unlock the potential of patient data?

Overview Patient level data offers the promise of insights which can craft new and better pathways, enable development

X

Can simulated datasets unlock the potential of patient data?

https://pharmaphorum.com/debates-insight-patients/can-simulated-datasets-unlock-the-potential-of-patient-data/

Partner Content

Inhale, Exhale: Living with Severe Asthma and Severe Eosinophilic Asthma

Inhale, Exhale: Living with Severe Asthma and Severe Eosinophilic Asthma

Findings from patient research about severe asthma

X

Inhale, Exhale: Living with Severe Asthma and Severe Eosinophilic Asthma

https://pharmaphorum.com/partner-content/inhale-exhale-living-with-severe-asthma-and-severe-eosinophilic-asthma/

People with Chronic Conditions Concerned About “Returning to Normal” During Pandemic

People with Chronic Conditions Concerned About “Returning to Normal” During Pandemic

People living with chronic conditions remain cautious

X

People with Chronic Conditions Concerned About “Returning to Normal” During Pandemic

https://pharmaphorum.com/partner-content/people-with-chronic-conditions-concerned-about-returning-to-normal-during-pandemic/

The ALS patient journey

The ALS patient journey

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). ALS is a progressive

X

The ALS patient journey

https://pharmaphorum.com/partner-content/the-als-patient-journey/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com